Opportunity
NIH Reporter #5U44AI124867-07
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites for NIH/NIAID malaria research
Buyer
National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, US
Posted
July 26, 2026
Identifier
5U44AI124867-07
NAICS
325414, 541714, 541715
This opportunity is issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for malaria research support: - Government Buyer: - National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) - OEMs and Vendors: - No specific OEMs or vendors are named in the solicitation - Products/Services Requested: - Manufacturing and development services for aseptic, purified, cryopreserved Plasmodium vivax sporozoites - No specific part numbers or purchase quantities provided - Unique or Notable Requirements: - Production of biological materials (Plasmodium vivax sporozoites) for research and vaccine development - Emphasis on quality control, safety, and efficacy testing - Support for controlled human malaria infection (CHMI) studies - Work to be performed in Rockville, Maryland - Estimated contract value: $1,000,000
Description
This procurement involves manufacturing and development of Plasmodium vivax sporozoites for malaria research and vaccine development. The project focuses on quality control, safety, and efficacy testing. It is funded by NIH/NIAID and aims to support controlled human malaria infection (CHMI) studies. The work is located in Rockville, MD, United States.